These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 16768127)
1. [NASH in children]. Ida S; Yoshimura N Nihon Rinsho; 2006 Jun; 64(6):1168-72. PubMed ID: 16768127 [TBL] [Abstract][Full Text] [Related]
2. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. Fishbein MH; Mogren C; Gleason T; Stevens WR J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):83-8. PubMed ID: 16385259 [TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic steatohepatitis in children. Nanda K Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336 [TBL] [Abstract][Full Text] [Related]
4. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841 [TBL] [Abstract][Full Text] [Related]
5. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related]
7. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
8. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Abrams GA; Kunde SS; Lazenby AJ; Clements RH Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453 [TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic steatohepatitis and the metabolic syndrome. Jiang J; Torok N Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830 [TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease. Leclercq I Bull Mem Acad R Med Belg; 2010; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266 [TBL] [Abstract][Full Text] [Related]
11. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
14. [Clinical features of NASH]. Shimada M; Takase S Nihon Rinsho; 2006 Jun; 64(6):1114-8. PubMed ID: 16768118 [TBL] [Abstract][Full Text] [Related]
15. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Cong WN; Tao RY; Tian JY; Liu GT; Ye F Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155 [TBL] [Abstract][Full Text] [Related]
16. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Targher G; Bertolini L; Rodella S; Lippi G; Franchini M; Zoppini G; Muggeo M; Day CP Obesity (Silver Spring); 2008 Jun; 16(6):1394-9. PubMed ID: 18369343 [TBL] [Abstract][Full Text] [Related]
17. Fatty liver disease in children. Marion AW; Baker AJ; Dhawan A Arch Dis Child; 2004 Jul; 89(7):648-52. PubMed ID: 15210498 [TBL] [Abstract][Full Text] [Related]